Schonfeld Strategic Advisors LLC Inovio Pharmaceuticals, Inc. Transaction History

Schonfeld Strategic Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.39 - $0.94 $41,997 - $101,225	107,687 New	107,687 $48,000
Q4 2022 Feb 14, 2023	SELL	$1.41 - $2.5 $137,556 - $243,895	-97,558 Reduced 34.41%	185,971 $290,000
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $266,640 - $448,149	160,627 Added 130.7%	283,529 $489,000
Q2 2022 Aug 15, 2022	BUY	$1.44 - $3.98 $161,138 - $445,369	111,902 Added 1017.29%	122,902 $213,000
Q1 2022 May 16, 2022	SELL	$2.97 - $5.2 $78,705 - $137,800	-26,500 Reduced 70.67%	11,000 $40,000
Q4 2021 Feb 14, 2022	BUY	$4.99 - $7.46 $73,353 - $109,662	14,700 Added 64.47%	37,500 $187,000
Q3 2021 Nov 16, 2021	SELL	$7.16 - $9.69 $233,065 - $315,419	-32,551 Reduced 58.81%	22,800 $163,000
Q2 2021 Aug 16, 2021	BUY	$6.23 - $10.03 $344,836 - $555,170	55,351 New	55,351 $514,000
Q1 2021 May 17, 2021	SELL	$8.81 - $16.96 $937,762 - $1.81 Million	-106,443 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$8.5 - $12.85 $818,541 - $1.24 Million	96,299 Added 949.32%	106,443 $942,000
Q3 2020 Nov 16, 2020	BUY	$9.57 - $27.05 $97,078 - $274,395	10,144 New	10,144 $118,000

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $459M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.